Gene: FAM219B
Official Full Name: family with sequence similarity 219 member Bprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17743 | FAM219B Knockout cell line (HeLa) | Human | FAM219B | 1:3~1:6 | Negative | Online Inquiry |
KO17744 | FAM219B Knockout cell line (HCT 116) | Human | FAM219B | 1:2~1:4 | Negative | Online Inquiry |
KO17745 | FAM219B Knockout cell line (HEK293) | Human | FAM219B | 1:3~1:6 | Negative | Online Inquiry |
KO17746 | FAM219B Knockout cell line (A549) | Human | FAM219B | 1:3~1:4 | Negative | Online Inquiry |
FAM219B Gene Knockout Cell Lines are advanced cellular tools specifically engineered to enable the study of the FAM219B gene, a crucial element implicated in various biological pathways and diseases. These genetically modified cell lines feature a complete knockout of the FAM219B gene, allowing researchers to investigate the gene's role in physiological processes and its contributions to pathologies like cancer and neurodegeneration.
The primary function of FAM219B Gene Knockout Cell Lines is to provide a controlled environment for understanding gene function and interactions. By observing cellular behavior in the absence of the FAM219B gene, researchers can elucidate the mechanisms by which this gene influences cellular activities, signaling pathways, and response to therapeutic agents. This knockout approach facilitates the identification of potential compensatory mechanisms and pathways that may be activated when the gene is disrupted.
The scientific importance of these cell lines is substantial, particularly in preclinical research settings. They serve as valuable models for drug screening, functional genomics, and the development of gene therapies. Their application can significantly improve the understanding of genetic contributions to disease, ultimately guiding the development of targeted treatments.
One of the distinct advantages of FAM219B Gene Knockout Cell Lines over traditional models is their precision and specificity. Unlike broad-spectrum inhibitors or general knockdown techniques, these knockout cell lines allow for a complete absence of the target gene, thereby eliminating confounding variables. Additionally, researchers benefit from the convenience of established protocols for use in various experimental designs, which accelerates the pace of discovery.
For researchers and clinicians seeking reliable models for studying gene function in health and disease, the FAM219B Gene Knockout Cell Lines offer an invaluable resource. These cell lines not only enhance the ability to investigate the FAM219B gene's function but also pave the way for innovative therapeutic strategies.
Our company specializes in providing high-quality biological products designed for cutting-edge research. With a commitment to scientific excellence and innovation, we ensure that our offerings, such as FAM219B Gene Knockout Cell Lines, meet the highest standards for reliability and performance in the laboratory.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.